Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 25, 2015 4:01 AM ET

Biotechnology

Company Overview of 3-V Biosciences, Inc.

Company Overview

3-V Biosciences, Inc. operates as a biopharmaceutical company that discovers and develops therapeutics for the treatment of oncology and infectious diseases. The company offers a TVB-2640, a fatty acid synthase inhibitor that blocks tumor cell signaling pathways and induces tumor cell apoptosis. It also focuses on developing antiviral therapeutic candidates for respiratory syncytial virus, cytomegalovirus, and other human pathogens. The company was incorporated in 2006 and is based in Menlo Park, California.

1050 Hamilton Court

Menlo Park, CA 94025

United States

Founded in 2006

Phone:

650-561-8600

Key Executives for 3-V Biosciences, Inc.

Chief Executive Officer, President and Director
Executive Chairman
Age: 49
Co-Founder
Co-Founder
Chief Financial Officer and Senior Vice President of Business & Financial Operations
Compensation as of Fiscal Year 2014.

3-V Biosciences, Inc. Key Developments

3-V Biosciences, Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-04-2015 11:30 AM

3-V Biosciences, Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-04-2015 11:30 AM. Venue: The Boston Marriott Copley Place, Boston, Massachusetts, United States. Speakers: Merdad V. Parsey, Chief Executive Officer, President and Director.

3-V Biosciences Appoints Rekha Hemrajani as Chief Financial Officer and SVP of Business and Financial Operations

3-V Biosciences, Inc. announced that Rekha Hemrajani has joined the company as its Chief Financial Officer, SVP of Business and Financial Operations. Prior to joining 3-V, Ms. Hemrajani spent the past fourteen years in the healthcare industry most recently as Vice President, Head of Licensing and M & A Group at Onyx Pharmaceuticals.

3-V Biosciences, Inc. Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-11-2014 09:10 AM

3-V Biosciences, Inc. Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-11-2014 09:10 AM. Venue: The Crowne Plaza Hotel, New York, New York, United States. Speakers: Merdad V. Parsey, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
Proteologics, Inc. United States
Progenesis Technologies, LLC United States
Tivorsan Pharmaceuticals, Inc United States
Embryome Sciences, Inc. United States
Direct Pharmaceutical United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
October 22, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact 3-V Biosciences, Inc., please visit www.3vbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.